Sponsors
The bill strengthens public and workplace safety by expanding and accelerating updates to drug-testing panels (including methadone) and standardizing rules, but it also risks harming workers in legitimate treatment, raises privacy and civil-liberties concerns, and imposes significant costs and implementation strains on employers and agencies.
Transportation workers, federal employees, and the public: drug tests will now include methadone and other newly identified dangerous substances, improving detection of impairment and likely reducing on-the-job and public-safety incidents.
Employers and safety agencies: aligning DOT testing with updated HHS Mandatory Guidelines creates more uniform testing standards across modes and agencies, simplifying compliance and enforcement.
Federal agencies and stakeholders: requiring HHS to review the Mandatory Guidelines annually and publish final revisions in the Federal Register increases transparency and keeps testing standards current.
Workers who take methadone or other legitimate medication-assisted treatments: face higher risk of positive drug tests and potential disciplinary or employment consequences if medical exceptions or appropriate evaluation procedures are not provided.
Employers, testing programs, labs, and taxpayers: will bear administrative, laboratory, equipment, and training costs to expand test panels, update policies, adjudicate results, and handle medical explanations.
Workers subject to broader and more frequent testing: face increased privacy and civil liberties concerns about the scope of substances tested and how results are collected, stored, and used.
Based on analysis of 5 sections of legislative text.
Introduced March 17, 2026 by Christopher Henry Smith · Last progress March 17, 2026
Requires the Department of Health and Human Services to add methadone to the opiate category in the Mandatory Guidelines for Federal Workplace Drug Testing within 90 days and publish a Federal Register notice. The Department of Transportation must update its regulations for transportation employee drug-testing panels to include methadone within 60 days after that notice. The bill also requires HHS to perform annual reviews of the Mandatory Guidelines and, if appropriate, add other substances to workplace testing panels, with DOT updating its transportation testing rules to follow those changes.